Advertisement
Advertise here Publish your press releases here Sponsor BioPortfolio
Follow us on Twitter Sign up for daily news and research emails Contributors wanted

InterMed Discovery GmbH Company Profile

09:33 EDT 16th April 2014 | BioPortfolio

InterMed Discovery is a world class natural product lead-discovery company, driving innovation through the generation of novel product candidates for the life science, food and cosmetics industries. Using one of the most powerful validated natural product discovery engines, InterMed Discovery generates proprietary product pipelines of functional ingredients and also supports partners in research and lead generation. Biologically characterised product leads are identified using IMD BIOPROFILING® and NPSilico®, which together comprise a proprietary bioinformatics platform drawing on screening results compiled over many years, complemented by primary biological and chemical research on natural products. InterMed Discovery adds to this the industry’s largest collections of pure compounds, sample fractions and mixtures as its source for potential natural product leads. The Company is located in Dortmund, Germany and was founded in 2006 as a management buyout of the Natural Products Research Unit of Bayer Healthcare. IMD entered into strategic cooperations with companies such as Cognis GmbH (now BASF SE) and Biotropics Malaysia Berhad. Further information on InterMed Discovery can be found at www.intermed-discovery.com.


News Articles [333 Associated News Articles listed on BioPortfolio]

Axxam, Hit Discovery Constance, Lead Discovery Center, Centre for Drug Design and Discovery (CD3) supply/service, high throughput screening news

MAB Discovery signs antibody development pact with Genmab

German firm MAB Discovery agreed to use its in vivo antibody discovery platform to generate antibodies for Genmab and its aff -More- 

Medivir AB to Use Certara’s Drug Discovery Platform

Certara, provider of software and scientific consulting services to improve productivity and decision-making from drug discovery through drug development, announced that Medivir AB, a Swedish pharmace...

Drug Discovery Today: January 2014 Issue.

The latest issue of Drug Discovery Today is packed full of industry focused research articles, new developments in drug discovery, and expert comment and opinion.

Drug Discovery Today: April 2014 Issue

The latest issue of Drug Discovery Today is packed full of industry focused research articles, new developments in drug discovery, and expert comment and opinion.

Drug Discovery Today: March 2014 Issue

The latest issue of Drug Discovery Today is packed full of industry focused research articles, new developments in drug discovery, and expert comment and opinion.

Heterodox discovery: Sidebar: Redx Pharma Ltd. Corporate Profile

Redx: Heterodox discovery Redx Pharma Ltd. Liverpool, U.K. Technology: Discovery platform that enables novel modifications to the core pharmacophore of existing compounds Disease focus: Cancer, infect...

Accomplished Scientist and Entrepreneur Selected to Lead Tri-Institutional Therapeutics Discovery Institute

Michael A. Foley, PhD, has been selected to lead the Tri-Institutional Therapeutics Discovery Institute, Inc. (Tri-I TDI), a pioneering collaboration of Weill Cornell Medical College, The Rockefeller...

PubMed Articles [404 Associated PubMed Articles listed on BioPortfolio]

Cancer epigenetics drug discovery and development: the challenge of hitting the mark.

Over the past several years, there has been rapidly expanding evidence of epigenetic dysregulation in cancer, in which histone and DNA modification play a critical role in tumor growth and survival. T...

ICR Expands CanSAR Drug Discovery Platform.

The UK's Institute of Cancer Research, London has broadened its CanSAR knowledgebase, a cancer drug-discovery platform that integrates genomic, chemical, and pharmacologic data. The newly released Can...

UK academic drug discovery.

Redesigning antidepressant drug discovery.

Antidepressant drug discovery and development have been put on hold by many pharmaceutical companies. The main reason for this is the negative efficacy studies with novel specific drugs. Here I argue...

China Plans Large Center for PDX Models.

The Chinese Academy of Sciences' Shanghai Institute of Materia Medica will collaborate with Crown Biosciences to build a collection of about 4,000 patient-derived xenograft models that will aid cancer...

Clinical Trials [38 Associated Clinical Trials listed on BioPortfolio]

Discovery Elbow Multi-Center Prospective Study

The purpose of this prospective clinical trial is to document the performance and clinical outcomes of Biomet Discovery Elbow.

Effects of a Multi-Faceted Psychiatric Intervention Targeted at the Complex Medically Ill: a Randomized Controlled Trial

Background: somatic patients with psychiatric co-morbidities are a major challenge for the health care system. This study evaluated a psychiatric intervention targeted at the complex medic...

A Clinical Investigation of the Discovery™ Elbow System

The purpose of this study is to perform a five-year, multi-center prospective evaluation of the Discovery™ Elbow System for outcome and durability. Relief of pain and restoration of fun...

Biomarker Discovery and Validation in Lung Cancer

Lung cancer is responsible for the most deaths due to cancer each year in both men and women worldwide and once diagnosed, the 10 year survival rate is poor (

DISCOVERY: Diagnostic Data and Genetic Polymorphisms in ICD Patients.

To prospectively evaluate if the analysis of genetic polymorphisms can be used to identify patients at risk of ventricular tachycardia. To evaluate the influence of ICD-based diagnostic i...

Companies [971 Associated Companies listed on BioPortfolio]

InterMed Discovery GmbH

InterMed Discovery is a world class natural product lead-discovery company, driving innovation through the generation of novel product candidates for the life science, food and co...

Discovery Health

Discovery Health Media includes the Discovery Health and FitTV television networks and online assets, including www.discoveryhealth.com, as well as its Continuing Medical Education (CME) business and...

Argenta Discovery Ltd.

Argenta Discovery is a privately held drug discovery company, applying its integrated medicinal chemistry, biology, ADMET and CADD expertise to drive drug discovery programmes. Argenta has a successfu...

Pyxis Discovery B.V.

The ambition of Pyxis Discovery is to be the preferred chemistry service provider for companies that are active in small molecule drug discovery. Pyxis Discovery's Smart approach of designing and...

Med Discovery SA

Med Discovery’s mission is the discovery and development of highly specific protein drugs to treat uro-genital cancers. By combining biological drug discovery expertise with a strong in-house knowle...

More Information about "InterMed Discovery GmbH" on BioPortfolio

We have published hundreds of InterMed Discovery GmbH news stories on BioPortfolio along with dozens of InterMed Discovery GmbH Clinical Trials and PubMed Articles about InterMed Discovery GmbH for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of InterMed Discovery GmbH Companies in our database. You can also find out about relevant InterMed Discovery GmbH Drugs and Medications on this site too.

Search BioPortfolio:
Advertisement

Corporate Database Quicklinks



Searches Linking to this Company Record

Advertisement